Impax Laboratories, Inc. (IPXL)

Lifshitz & Miller announces investigation on behalf of IPXL investors concerning whether IPXL engaged in a scheme to fix generic drug prices with other pharmaceutical companies.

If you are a IPXL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.